Lyell Immunopharma (LYEL) Net Margin Growth (1y) (2021 - 2026)
Lyell Immunopharma (LYEL) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lyell Immunopharma | 298.14 Mn | 298.14 Mn | - | -331.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -331.96 Mn |
| Dec 31, 2025 | 268.90 Mn |
| Sep 30, 2025 | -31.52 Mn |
| Jun 30, 2025 | -44.73 Mn |
| Mar 31, 2025 | 65.58 Mn |
| Dec 31, 2024 | -274.02 Mn |
| Sep 30, 2024 | -8.57 Mn |
| Jun 30, 2024 | -65.97 Mn |
| Mar 31, 2024 | -236.88 Mn |
| Dec 31, 2023 | -235.99 Mn |
| Sep 30, 2023 | 599.91 Mn |
| Jun 30, 2023 | -33.60 Mn |
| Mar 31, 2023 | -9.65 Mn |
| Dec 31, 2022 | 585,024.00 |
| Sep 30, 2022 | -627.71 Mn |
| Jun 30, 2022 | 625,369.00 |
| Mar 31, 2022 | -2.94 Mn |
| Dec 31, 2021 | 3,488.00 |
| Sep 30, 2021 | 129,785.00 |
| Jun 30, 2021 | -333,124.00 |